Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole

This study has been completed.
Sponsor:
Collaborator:
Tel-Aviv Sourasky Medical Center
Information provided by (Responsible Party):
David B. Geffen, Soroka University Medical Center
ClinicalTrials.gov Identifier:
NCT00376740
First received: September 14, 2006
Last updated: August 22, 2011
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
No publications provided by Soroka University Medical Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):